Abstract
Of 12 adult patients with high‐grade soft tissue sarcoma receiving adjuvant chemotherapy and at risk for 36–84 months, 9 (75%) remain metastasis free and 10 (83%) have adequate local disease control with limb preservation. This is significantly better (P > 0.015) than a comparable “historic” control of 48 previously treated patients. The results correlate well with the few similar studies reported.